BioClec

BioClec is a biotechnology company dedicated to developing groundbreaking innovative therapies for Alzheimer's disease. The company focuses on advancing breakthrough treatments targeting microglia, the key immune cell population in the brain. BioClec is poised to make a significant impact on the treatment of neurodegenerative diseases, addressing unmet urgent medical needs of patients worldwide.